Spots Global Cancer Trial Database for Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Official Title: A Randomised Phase II Study Comparing Anastrozole and Fulvestrant to Anastrozole for Adjuvant Treatment of Postmenopausal Patients With Early Breast Cancer and Disseminated Tumour Cells in Bone Marrow
Study ID: NCT00357110
Conditions
Study Description
Brief Summary: Purpose is to compare the frequency of events (presence of Disseminated Tumour Cells, clinical recurrence and/or death) after 1 and 2 years of adjuvant treatment with anastrozole and fulvestrant or anastrozole alone in patients with early breast cancer.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Feldkirch, , Austria
Research Site, Graz, , Austria
Research Site, Innsbruck, , Austria
Research Site, Klagenfurt, , Austria
Research Site, Leoben, , Austria
Research Site, Linz, , Austria
Research Site, Salzburg, , Austria
Research Site, St. Veit, , Austria
Research Site, Wiener Neustadt, , Austria
Research Site, Wien, , Austria
Research Site, Bayreuth, , Germany
Research Site, Essen, , Germany
Research Site, Hamburg-Eppendorf, , Germany
Research Site, Heidelberg, , Germany
Research Site, Munich, , Germany
Research Site, Rostock, , Germany
Research Site, Tubingen, , Germany
Research Site, Drammen, , Norway
Research Site, Fredrikstad, , Norway
Research Site, Kristiansand, , Norway
Research Site, Oslo, , Norway
Research SIte, Porsgrunn, , Norway
Research Site, Stavanger, , Norway
Research Site, Tonsberg, , Norway
Research Site, Trondheim, , Norway
Contact Details
Name: Breast Cancer Established Brands Team Medical Science Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
